IEZZA, MIRIAM
 Distribuzione geografica
Continente #
EU - Europa 17
AS - Asia 4
NA - Nord America 3
AF - Africa 1
SA - Sud America 1
Totale 26
Nazione #
IT - Italia 10
SG - Singapore 4
US - Stati Uniti d'America 3
CH - Svizzera 2
DE - Germania 2
IE - Irlanda 2
BR - Brasile 1
CI - Costa d'Avorio 1
SE - Svezia 1
Totale 26
Città #
Bologna 6
Singapore 4
Bern 2
Dublin 2
Grand Forks 2
Abidjan 1
Los Angeles 1
Rostock 1
São Paulo 1
Totale 20
Nome #
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report 11
Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study 10
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights 10
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib 7
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study 3
Totale 41
Categoria #
all - tutte 365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 365


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20236 0 0 0 0 1 0 0 0 0 1 0 4
2023/202428 0 0 0 0 0 5 3 5 2 8 4 1
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 41